LDS/Medical Tests/Biopsy, Lymph Node

Biopsy, Lymph Node

Biopsy of a lymph node is a test in which a lymph node or portion of the node is removed and submitted to the laboratory for histopathologic examination and often for special studies such as flow cytometry, cytogenetics, and sometimes cultures. Biopsies are usually indicated for node enlargement; sometimes one node is enlarged and sometimes more than one. Biopsies are indicated to evaluate for suspected lymphoma, suspected metastatic carcinoma, unexplained enlargement, and suspected infection. Occasionally, a frozen section is done to ensure adequacy of the biopsy and sometimes the frozen section is diagnostic, but it is unusual for a definitive diagnosis to be rendered at frozen section. Handling of the lymph node at the time of biopsy is dictated by the clinical situation.

Most biopsies are done in adults for unexplained enlargement. In this case, a portion of the node is submitted in a sterile fashion for bacterial, fungal, and mycobacterial cultures, a portion is submitted for flow cytometry, and the remainder is submitted for histopathologic examination. If the permanent sections show unequivocal lymphoma or metastatic carcinoma, the cultures can be cancelled.

Some lymph nodes are biopsied as part of a cancer staging procedure such as breast cancer and lung cancer. Breast cancer node staging is often done as a frozen section of a sentinel node in which the surgeon employs a marker dye and radioactive substance injected in the breast near a tumor; the axillary node containing the dye and radioactive material is the sentinel node and is excised by the surgeon and submitted for frozen section analysis. In lung cancer, certain nodes draining the involved lung are sometimes biopsied to evaluate for metastatic carcinoma. If a node shows lymphoma on histopathologic examination, the cell type and pattern of node involvement is determined. This is correlated with the flow cytometry studies. Hodgkin lymphoma and some large B cell lymphomas will yield a negative flow cytometry study so that the only means of making the diagnosis is histopathologic examination, almost always in conjunction with immunohistochemistry stain studies.

  • To evaluate unexplained enlargement of lymph nodes
  • To evaluate for metastatic carcinoma
  • To stage for metastatic carcinoma in certain clinical situations such as breast and lung cancer
  • To evaluate for an infectious process and simultaneously exclude a neoplastic process such as lymphogranuloma venereum
  • To evaluate for metastatic carcinoma and lymphoma is identified
Interpretation of lymph node biopsy findings is dependent on the clinical situation, histopathologic findings, and flow cytometry findings.

Normal lymph node
 

 

 

Lymph nodes are excised and usually submitted fresh to the laboratory for histopathology including immunohistochemistry studies, flow cytometry, and culture studies.

Lymph node handling depends upon the clinical situation. Biopsies to exclude lymphoma should be submitted fresh to the laboratory and portions submitted for flow cytometry and culture as well as histopathology. Axillary nodes excised as part of breast cancer staging are usually submitted fresh for frozen section histopathology. Enlarged lymph nodes are sometimes evaluated by fine needle aspiration (FNA), sometimes using real-time adequacy assessment. FNA does not yield intact tissue and may not be adequate to assess the pattern or degree of node involvement and occasionally may yield a false negative due to sampling error. Correlation between FNA and excisional biopsy diagnosis in lymphoma is poor, and in general excision is recommended for a specific and complete diagnosis using an accepted classification system.

CBC, Culture studies, Flow cytometry, Immunohistochemistry.
24 hours for initial light microscopy histopathology. 24 hours for Flow cytometry of lymphoma. 24 - 72 hours for Immunohistochemistry histopathology, depending upon complexity.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Asian Pac J Cancer Prev. 2011;12(7):1873-5. PMID: 22126582]
  • Mayo Clin Proced. 2000; 75(7): 723-32. [PMID: 10907389]
  • Am J Clin Pathol. 1995; 103(5): 543-60. [PMID: 7741099]
  • Jaffe ES, et al. Hematopathology. Elsevier Saunders, Philadelphia, PA (2011).
  • Knowles DM. Neoplastic Hematopathology. Baltimore, MD; Lippincott Williams & Wilkins (2002).
  • Jaffe ES, et al. "Tumours of Haematopoietic and Lymphoid Tissues." World Health Organization Classification of Tumors series. IARC Press (2001).